Skip to main content

Advertisement

Log in

The activation of extracellular signal-regulated kinase is responsible for podocyte injury

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Podocyte and its slit diaphragm play an important role in maintaining normal glomerular filtration barrier function and structure. Podocyte apoptosis and slit diaphragm injury leads to proteinuria and glomerulosclerosis. However, the molecular mechanism of podocyte injury remains poorly understood. The family of mitogen-activated protein kinases including extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase, and p38 signal pathways, are implicated in the progression of various glomerulopathies. However, the role of the activated signal pathway(s) in podocyte injury is elusive. This study examined phosphorylation of ERK in rat puromycin aminonucleoside (PAN) nephropathy as well as conditionally immortalized mouse podocyte treated with PAN in vitro. The effect of treatment with U0126, an inhibitor of ERK, was also investigated. In PAN nephropathy, the phosphorylation of ERK was marked. In podocyte injury, the marked and sustained activation of ERK pathway was also observed before the appearance of significant podocyte apoptosis. Pretreatment with U0126 to podocyte completely inhibited ERK activation, with complete suppression podocyte apoptosis and ameliorated nephrin protein expression along with the phosphorylation of nephrin in podocyte injury. In cultured podocyte, PAN induced actin recorganition, and U0126 inhibited such change. However, U0126 did not recovery the phosphorylation change of neph1 in podocyte injury. We concluded that the sustained activation of ERK along with the phosphorylation of neph1 might be necessary for podocyte injury. The study here suggested that ERK might become a potential target for therapeutic intervention to prevent podocytes from injury which will result in proteinuria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Kriz W, Hackenthal E, Nobiling R et al (1994) A role for podocytes to counteract capillary wall distension. Kidney Int 45:369–376

    Article  CAS  PubMed  Google Scholar 

  2. Kestila M, Lenkkeri U, Mannikko M et al (1998) Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome. Mol Cell 1:575–582

    Article  CAS  PubMed  Google Scholar 

  3. Shaw AS, Miner JH (2001) CD2-associated protein and the kidney. Curr Opin Nephrol Hypertens 10(1):9–22

    Google Scholar 

  4. Shih NY, Karpitskii V, Nguyen A, Dustin ML, Kanagawa O, Miner JH, Shaw AS (1999) Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 286:312–315

    Article  CAS  PubMed  Google Scholar 

  5. Boute N, Gribouval O, Roselli S et al (2000) NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24:349–354

    Article  CAS  PubMed  Google Scholar 

  6. Kaplan JM, Kim SH, North KN et al (2000) Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 24:251–256

    Article  CAS  PubMed  Google Scholar 

  7. Laurens W, Battaglia C, Foglieni C et al (1995) Direct podocyte damage in the single nephron leads to albuminuria in vivo. Kidney Int 47:1078–1086

    Article  CAS  PubMed  Google Scholar 

  8. Pavenstadt H (1998) The charge for going by foot: modifying the surface of podocytes. Exp Nephrol 6:98–103

    Article  CAS  PubMed  Google Scholar 

  9. Koshikawa M, Mukoyama M, Mori K et al (2005) Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J Am Soc Nephrol 16:2690–2701

    Article  CAS  PubMed  Google Scholar 

  10. Chowdhury I, Chaqour B (2004) Regulation of connective tissue growth factor (CTGF/CCN2) gene transcription and mRNA stability in smooth muscle cells. Involvement of RhoA GTPase and p38 MAP kinase and sensitivity to actin dynamics. Eur J Biochem 271(443):6–50

    Google Scholar 

  11. Huber TB, Hartleben B, Kim J et al (2003) Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol 23:4917–4928

    Article  CAS  PubMed  Google Scholar 

  12. Huber TB, Kottgen M, Schilling B et al (2001) Interaction with podocin facilitates nephrin signaling. J Biol Chem 276:41543–41546

    Article  CAS  PubMed  Google Scholar 

  13. Huber TB, Schmidts M, Gerke P et al (2003) The carboxyl terminus of Neph family members binds to the PDZ domain protein zonula occludens-1. J Biol Chem 278:13417–13421

    Article  CAS  PubMed  Google Scholar 

  14. Huber TB, Simons M, Hartleben B et al (2003) Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Hum Mol Genet 12:3397–3405

    Article  CAS  PubMed  Google Scholar 

  15. Jakubikova J, Sedlak J, Mithen R et al (2005) Role of PI3K/Akt and MEK/ERK signaling pathways in sulforaphane- and erucin-induced phase II enzymes and MRP2 transcription, G2/M arrest and cell death in Caco-2 cells. Biochem Pharmacol 69:1543–1552

    Article  CAS  PubMed  Google Scholar 

  16. Motomura W, Tanno S, Takahashi N et al (2005) Involvement of MEK-ERK signaling pathway in the inhibition of cell growth by troglitazone in human pancreatic cancer cells. Biochem Biophys Res Commun 332:89–94

    Article  CAS  PubMed  Google Scholar 

  17. Chen CA, Tsai JC, Su PW et al (2006) Signaling and regulatory mechanisms of integrinalpha3beta1 on the apoptosis of cultured rat podocytes. J Lab Clin Med 147:274–280

    Article  CAS  PubMed  Google Scholar 

  18. Gu L, Ni Z, Qian J et al (2007) Pravastatin inhibits carboxymethyllysine-induced monocyte chemoattractant protein 1 expression in podocytes via prevention of signalling events. Nephron Exp Nephrol 106:e1–e10

    Article  CAS  PubMed  Google Scholar 

  19. Bai Y, Wang L, Li Y et al (2006) High ambient glucose levels modulates the production of MMP-9 and alpha5(IV) collagen by cultured podocytes. Cell Physiol Biochem 17:57–68

    Article  CAS  PubMed  Google Scholar 

  20. Wada T, Pippin JW, Nangaku M et al (2008) Dexamethasone’s prosurvival benefits in podocytes require extracellular signal-regulated kinase phosphorylation. Nephron Exp Nephrol 109:e8–e19

    Article  CAS  PubMed  Google Scholar 

  21. Kriz W, Gretz N, Lemley KV (1998) Progression of glomerular diseases: is the podocyte the culprit? Kidney Int 54:687–697

    Article  CAS  PubMed  Google Scholar 

  22. Pagtalunan ME, Miller PL, Jumping-Eagle S et al (1997) Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99:342–348

    Article  CAS  PubMed  Google Scholar 

  23. Lemley KV, Lafayette RA, Safai M et al (2002) Podocytopenia and disease severity in IgA nephropathy. Kidney Int 61:1475–1485

    Article  PubMed  Google Scholar 

  24. Sahai E, Olson MF, Marshall CJ (2001) Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J 20:755–766

    Article  CAS  PubMed  Google Scholar 

  25. Pawlak G, Helfman DM (2002) MEK mediates v-Src-induced disruption of the actin cytoskeleton via inactivation of the Rho-ROCK-LIM kinase pathway. J Biol Chem 277:26927–26933

    Article  CAS  PubMed  Google Scholar 

  26. Vial E, Sahai E, Marshall CJ (2003) ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 4:67–79

    Article  CAS  PubMed  Google Scholar 

  27. Bijian K, Takano T, Papillon J et al (2005) Actin cytoskeleton regulates extracellular matrix-dependent survival signals in glomerular epithelial cells. Am J Physiol Renal Physiol 289:F1313–F1323

    Article  CAS  PubMed  Google Scholar 

  28. Sellin L, Huber TB, Gerke P et al (2003) NEPH1 defines a novel family of podocin interacting proteins. FASEB J 17:115–117

    CAS  PubMed  Google Scholar 

  29. Kawachi H, Koike H, Kurihara H et al (2000) Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states. Kidney Int 57:1949–1961

    Article  CAS  PubMed  Google Scholar 

  30. Yu CC, Yen TS, Lowell CA et al (2001) Lupus-like kidney disease in mice deficient in the Src family tyrosine kinases Lyn and Fyn. Curr Biol 11:34–38

    Article  CAS  PubMed  Google Scholar 

  31. Harita Y, Kurihara H, Kosako H et al (2008) Neph1, a component of the kidney slit diaphragm, is tyrosine-phosphorylated by the Src family tyrosine kinase and modulates intracellular signaling by binding to Grb2. J Biol Chem 283:9177–9186

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Professor Peter Mundel (America) for the podocyte cell line, Professor Karl Tryggvason (Sweden) and Professor Corinne Antignac (France) for the gifts of nephrin and podocin antibodies, respectively. This study was supported by the National Nature Science Foundation of China (30672259), Nature Science Foundation of Beijing (7072080).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jie Ding.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, S., Ding, J., Fan, Q. et al. The activation of extracellular signal-regulated kinase is responsible for podocyte injury. Mol Biol Rep 37, 2477–2484 (2010). https://doi.org/10.1007/s11033-009-9761-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-009-9761-6

Keywords

Navigation